(Q44598660)

English

A new multidrug reinduction protocol with topotecan, vinorelbine, thiotepa, dexamethasone, and gemcitabine for relapsed or refractory acute leukemia

scientific article published on October 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 December 2017

A new multidrug reinduction protocol with topotecan, vinorelbine, thiotepa, dexamethasone, and gemcitabine for relapsed or refractory acute leukemia (English)

1 reference

Europe PubMed Central

4 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

10.1038/SJ.LEU.2403097

https://api.crossref.org/works/10.1038/SJ.LEU.2403097

15 March 2024

author name string

E. A. Kolb

1

0000-0003-2854-9014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14513046

15 March 2024

P. G. Steinherz

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14513046

15 March 2024

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14513046

15 March 2024

publication date

1 October 2003

1 reference

Europe PubMed Central

4 December 2017

full work available at URL

https://www.nature.com/articles/2403097.pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14513046

15 March 2024

https://www.nature.com/articles/2403097.pdf

Portable Document Format

1 reference

10.1038/SJ.LEU.2403097

https://api.crossref.org/works/10.1038/SJ.LEU.2403097

15 March 2024

https://www.nature.com/articles/2403097

1 reference

10.1038/SJ.LEU.2403097

https://api.crossref.org/works/10.1038/SJ.LEU.2403097

15 March 2024

1 reference

Europe PubMed Central

4 December 2017

17

1 reference

Europe PubMed Central

4 December 2017

10

1 reference

Europe PubMed Central

4 December 2017

1967-1972

1 reference

Europe PubMed Central

4 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403097

0 references

Synthesis of water-soluble (aminoalkyl)camptothecin analogs: inhibition of topoisomerase I and antitumor activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403097

21 January 2018

Activity of topotecan, a new topoisomerase I inhibitor, against human tumor colony-forming units in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403097

21 January 2018

The current status of camptothecin analogues as antitumor agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403097

21 January 2018

Topoisomerase I inhibitors: topotecan and irenotecan

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403097

21 January 2018

Phase I clinical and laboratory evaluation of topotecan and cytarabine in patients with acute leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403097

21 January 2018

Idarubicin, cytarabine, and topotecan in patients with refractory or relapsed acute myelogenous leukemia and high-risk myelodysplastic syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403097

21 January 2018

Treatment of refractory acute leukemia with timed sequential chemotherapy using topotecan followed by etoposide + mitoxantrone (T-EM) and correlation with topoisomerase II levels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403097

21 January 2018

Cytotoxic effects of topotecan combined with various anticancer agents in human cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403097

21 January 2018

Cyclophosphamide, ara-C and topotecan (CAT) for patients with refractory or relapsed acute leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403097

21 January 2018

Phase I and pharmacologic study of continuous infusion topotecan in combination with cisplatin in patients with advanced cancer: a Cancer and LeukemiaGroup B study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403097

21 January 2018

Topotecan combined with myeloablative doses of thiotepa and carboplatin for neuroblastoma, brain tumors, and other poor-risk solid tumors in children and young adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403097

21 January 2018

Vinorelbine induces apoptosis and caspase-3 (CPP32) expression in leukemia and lymphoma cells: a comparison with vincristine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403097

21 January 2018

In vitro activity of vinorelbine on human leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403097

21 January 2018

New chemotherapy agents for small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403097

21 January 2018

Clinical and preclinical activity of 2',2'-difluorodeoxycytidine (gemcitabine).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403097

21 January 2018

Treatment of refractory T-cell malignancies using gemcitabine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403097

21 January 2018

Phase I study of gemcitabine (difluorodeoxycytidine) in children with relapsed or refractory leukemia (CCG-0955): a report from the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403097

21 January 2018

Phase I evaluation of prolonged-infusion gemcitabine with irinotecan for relapsed or refractory leukemia or lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403097

21 January 2018

Improved response with higher corticosteroid dose in children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403097

21 January 2018

Combination of topotecan with cytarabine or etoposide in patients with refractory or relapsed acute myeloid leukemia: results of a randomized phase I/II study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403097

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination effect of navelbine (vinorelbine ditartrate) with cisplatin against murine P388 leukemia and human lung carcinoma xenografts in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403097

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of vinorelbine on B-chronic lymphocytic leukemia cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403097

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of antineoplastic activity of 2',2'-difluorodeoxycytidine and cytosine arabinoside against human myeloid and lymphoid leukemic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403097

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of apoptosis using 2′,2′difluorodeoxycytidine (gemcitabine) in combination with antimetabolites or anthracyclines on malignant lymphatic and myeloid cells. Antagonism or synergism depends on incubation schedule and origin of neoplastic

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403097

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of gemcitabine (2',2'-difluoro-deoxycytidine) and 2-chlorodeoxyadenosine on growth of normal and leukemic cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403097

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine in leukemia: a phase I clinical, plasma, and cellular pharmacology study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403097

7 January 2021

based on heuristic

inferred from DOI database lookup

Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403097

7 January 2021

based on heuristic

inferred from DOI database lookup

17

86

440

author name string

L Pagano

publication date

2001

1 reference

10.1038/SJ.LEU.2403097

https://api.crossref.org/works/10.1038/SJ.LEU.2403097

15 March 2024

Identifiers

10.1038/SJ.LEU.2403097

1 reference

Europe PubMed Central

4 December 2017

1 reference

Europe PubMed Central

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44598660&oldid=2103804440"